HomeNKTR • NASDAQ
Nektar Therapeutics
add
$0.69
1.14%
After Hours:(2.47%)-0.017
$0.67
Closed: May 20, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.46M | -51.66% |
Operating expense | 54.83M | 15.28% |
Net income | -50.88M | -38.26% |
Net profit margin | -486.44 | -186.02% |
Earnings per share | -0.24 | -30.65% |
EBITDA | -43.94M | -33.78% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.63M | -24.41% |
Total assets | 256.24M | -35.29% |
Total liabilities | 242.50M | -9.95% |
Total equity | 13.74M | — |
Shares outstanding | 186.10M | — |
Price to book | 9.93 | — |
Return on assets | -39.61% | — |
Return on capital | -48.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -50.88M | -38.26% |
Cash from operations | -49.05M | -2.43% |
Cash from investing | 43.69M | 126.86% |
Cash from financing | 7.00K | -99.98% |
Net change in cash | -5.36M | -140.09% |
Free cash flow | -24.17M | -20.73% |
Previous close
$0.70
Day range
$0.66 - $0.70
Year range
$0.43 - $1.75
Market cap
126.96M USD
Avg Volume
2.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1990
Headquarters
Website
Employees
61
